驗證網址www.wikijournalclub.org安全性

ATLAS ACS-2, TIMI 51 - Wiki Journal Club

Clinical Question In patients with recent ACS, does the addition of rivaroxaban to standard dual antiplatelet therapy improve CV morbidity and mortality? Bottom Line In patients with recent ACS, the addition of rivaroxaban to standard dual antiplatelet th...

網址安全性掃描由 google 提供